Rutgers-Affiliated Start-Up Company Receives Funding for Technology to Help Choose Breast Cancer Treatments

The National Institutes of Health (NIH) has awarded a Rutgers-affiliated company $207,000 to develop a quick and economical analysis of tissue from breast cancer biopsies. The technology is designed to predict how aggressive a common form of breast cancer is likely to be, helping physicians and patients plan effective therapies that minimize side effects.

The NIH made its grant to Ibris, Inc., through the Small Business Innovation Research program, which federal funding agencies use to encourage American businesses to engage in research and development with commercial potential. Ibris, Inc. is a Piscataway-based start-up company that is negotiating a license for computerized image recognition technology developed by Anant Madabhushi, professor of biomedical engineering in the Rutgers School of Engineering.

Madabhushi credits the Rutgers Office of Technology Commercialization for assistance in licensing the technology and creating Ibris, Inc. He also credits the university’s Center for Innovative Ventures of Emerging Technologies (CIVET) for helping to arrange early-stage funding for the start-up company and business plan assistance from the Rutgers Business School.

Read the full article